The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to McGuire et al., N Engl J Med 334(1):1-6 January 4, 1996.

Correction
PreviousPrevious
Volume 334:1070 April 18, 1996 Number 16
NextNext

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

 

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by McGuire, W. P.
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer . On page 1, in the Results paragraph of the Abstract, the fourth sentence should have read, "Among 216 women with measurable disease, 51 percent of the cisplatin–paclitaxel group had a complete response to therapy and 22 percent a partial response, whereas 31 percent of the cisplatin–cyclophosphamide group had a complete response and 29 percent a partial response (P = 0.01, {xi}22 = 8.97)."



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.